Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Typhoid vaccine.

  • Comment

VOL: 101, ISSUE: 34, PAGE NO: 37

Generic and proprietary names

Generic and proprietary names
- Polysaccharide typhoid vaccine.

- Typherix.

- Typhim Vi.

- Typhoid vaccine (oral).

- Vivotif.

- Combined typhoid and hepatitis A vaccines are also available.

- Immunological products and vaccines.

- Vaccines and antisera.

- Travellers from non-endemic to disease-endemic regions although it is not a substitute for careful personal hygiene.

- Laboratory workers handling samples from suspect cases.


- Known sensitivity or allergy to any ingredient.

- Decreased immune response due to diseases such as leukaemia, lymphoma or an HIV infection.

- Persistent vomiting or diarrhoea.

- Acute feverish illness.

- Gastrointestinal conditions.

- Known sensitivity or allergy to any ingredient.

- Acute feverish illness.

- Pregnancy - typhoid vaccine should only be given if a clear indication exists.

- Not usually recommended for children under one year of age. Oral vaccine is not suitable for children under six years of age.


- Abdominal cramps.

- Diarrhoea, nausea and vomiting.

- Urticaria.


- Fever.

- Headache.

- Erythema or induration of more than 1cm at injection site.


- Antibiotics, mefloquine or sulphonamides may inactivate the vaccine.


- The enteric-coated capsules should be swallowed whole, about one hour before a meal, with a cold or lukewarm drink.

- Three doses are taking on alternate days (day one, three and five).

- Can be given simultaneously with other vaccines relevant for international travellers.

Nursing considerations
- Antibiotics should be avoided during the three days before and after oral administration.

- Travellers from non-endemic to disease-endemic regions are recommended a booster on a yearly basis for oral and every three years for injections.

- Recommended storage temperature is between 2 degsC and 8 degsC.

- Consult a recognised source of information when recommending vaccinations to travellers.

- It is usually considered good practice to provide patients with a record of the immunisations they have been given and dates for boosters.

Patient teaching
- Inform patients that they may need to return for booster doses if they continue to travel to risk areas.

- Ensure that patients are aware of food and water hygiene precautions.

- The vaccine confers protection seven days after an injection and seven to ten days after an oral course.

Nurses should refer to manufacturer's summary of product characteristics and to appropriate local guidelines

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.